This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2016
Title: Innovations and Contributions of Sabira Begum
Introduction
Sabira Begum is a notable inventor based in Karachi, Pakistan. She has made significant contributions to the field of medical research, particularly in the development of novel compounds for treating epilepsy and tuberculosis. With a total of 2 patents, her work reflects a commitment to advancing healthcare solutions.
Latest Patents
One of her latest patents focuses on the modulation of c-FOS and BDNF protein expression in pentylenetetrazole-kindled mice following treatment with the novel anti-epileptic compound HHL-6. This invention evaluates the anti-epileptogenic effect of the tryptamine derivative HHL-6 and its impact on the expression of BDNF and c-Fos. The findings suggest that HHL-6 possesses potent anticonvulsant and anti-epileptic activity in PTZ-induced acute seizure and chemical kindling models of epilepsy. The results indicate that one possible mechanism by which HHL-6 inhibits epileptogenesis may be through its regulatory effect on the cellular and molecular expression of factors contributing to the development of epileptogenic plasticity in the central nervous system.
Her second patent involves steroidal antitubercular compounds, specifically a steroidal compound n-hexyl-p-stigmasteryloxy-benzoate, which is reported as a novel potent antitubercular drug. This innovation highlights her dedication to addressing critical health challenges.
Career Highlights
Sabira Begum's career is marked by her innovative research and dedication to improving medical treatments. Her work has garnered attention in the scientific community, showcasing her ability to develop effective solutions for complex health issues.
Collaborations
Throughout her career, Sabira has collaborated with esteemed colleagues, including Bina Shaheen Siddiqui and Shabana Usman Simjee. These partnerships have further enriched her research and contributed to her success as an inventor.
Conclusion
Sabira Begum's contributions to medical research through her patents demonstrate her innovative spirit and commitment to improving healthcare. Her work in developing new treatments for epilepsy and tuberculosis is a testament to her impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile